You are here

News

New progresses for infant HIV vaccine development

24 September, 2014

A possible breakthrough in the development of an HIV vaccine for infants has been announced by researches of Duke University.

Read more >>

Global summit focuses on HIV treatment targets as the way forward

19 September, 2014

Ending the AIDS epidemic as a global health threat is possible, and within reach, if resources are pooled effectively according to global leaders, leading academics, policy makers and people in the treatment industry and the HIV community at the annual summit, Controlling the HIV Epidemic with Antiretrovirals

Read more >>

HIV self-testing effective for reaching MSM in China

17 September, 2014

Self-testing for HIV can be an effective way of increasing uptake of HIV testing and reaching high risk sub-groups of men who have sex with men (MSM) in China. An online survey conducted in China, found that 20.3 percent of MSM in the country had self-tested for HIV at least once in their lives.

Read more >>

HIV positive mothers likely to stop treatment after delivery

15 September, 2014

Mothers living with HIV in South Africa often discontinue HIV care after their child is born and has tested negative for HIV, as they perceive their own health as unimportant.

Read more >>

The war on drugs has failed: Global Commission on Drug Policy launches new report

12 September, 2014

The Global Commission on Drug Policy met this week in New York for the launch their new report, Taking Control: pathways to drug policies that work. The report calls on world leaders and policymakers to re-think and reform global drug policy, moving away from the ‘war on drugs’ stance, which they argue has failed, to a stance focused on human rights and access to healthcare.

Read more >>

Visceral leishmaniasis-HIV co-infection an emerging global health issue

10 September, 2014

Visceral leishmaniasis-HIV (VL/HIV) co-infection is an emerging global health issue, prominent in Africa, and on the rise in South America and India. Visceral leishmaniasis (VL) is a disease that develops from the leishmaniasis parasite, which is transmitted via the bite of a sand fly. VL is the biggest global parasite killer after malaria, and is a major concern for people living with HIV (PLHIV) as a potentially life threatening co-infection.

Read more >>

Drugs shortage in free antiretroviral treatment programs in India is trouble for the poor

9 September, 2014

Shortages of antiretroviral treatment in India cause that many people living with HIV are unable to access the needed drugs through government run distribution centres.

Read more >>

Targeting high-risk groups with HIV prevention services cost-effective for public health

5 September, 2014

Large-scale HIV prevention programmes targeted at high-risk populations can be enormously cost-effective for public health, according to new research conducted on the Avahan HIV prevention programme in India. The researchers found that in a concentrated epidemic, targeting services at key affected populations, including sex workers and men who have sex with men, will be effective both in averting new infections, and prove to be value for money over time.

Read more >>

Pages